On January 1, 2020, Blossom Corporation granted 20,700 options to key executives. Each option allows the executive to purchase one share of Blossom's common shares at a price of $26 per share. The options were exercisable within a two-year period beginning January 1, 2022, if the grantee was still employed by the company at the time of the exercise. On the grant date, Blossom's shares were trading at $21 per share, and a fair value options pricing model determined total compensation to be $790,000. Management has assumed that there will be no forfeitures because they do not expect any of the key executives to leave On May 1, 2022,6,210 options were exercised when the market price of Blossom's shares was $32 per share. The remaining options lapsed in 2023 because executives decided not to exercise them. Management was indeed correct in their assumption regarding forfeltures in that all executives remained with the company. Assume that Blossom follows IFRS. Prepare the necessary journal entries related to the stock option plan for the years ended December 31, 2020 through 2020 (Credit account titles are automatically indented when the amount is entered. Do not indent manually. If no entry is required, select "No Entry for the account titles and enter o for the amounts.) Prepare the necessary Journal entries related to the stock option plan for the years ended December 31, 2020 through 2023 (Credit account titles are automatically indented when the amount is entered. Do not indent manually. If no entry is required, select "No Entry for the account titles and enter for the amounts.) Account Titles and Explanation Debit 1/1/20 Date Credit 12/31/20 12/31/21 5/1/22 12/31/23